Venous Thromboembolism Treatment Market Overview and Industry Growth, Forecast, 2029

Allied Analytics

Key drivers, restraints, and opportunities along with a detailed analysis of the global Venous Thromboembolism Treatment Market share.

PORTLAND, OREGON, USA, March 25, 2022 / — According to a new report published by Allied Market Research, titled “Venous Thromboembolism Treatment Market: Global Opportunity Analysis and Industry Forecast, 2022-2029” Venous thromboembolism (TEV ) is a condition in which a blood clot most commonly forms in the deep veins of the leg, groin, or arm (known as deep vein thrombosis, DVT) and travels through the circulation, becoming lodged in the lungs (known as a pulmonary embolism, PE). Together, DVT and PE are known as VTE – a dangerous and life-threatening medical condition. VTE is one of the leading causes of death and disability worldwide. A thorough scientific review by the WTD Steering Committee found that 10 million cases of VTE occur each year across low, middle and high income countries.

Growth in the number of diseases that can be monitored and tracked using IoT medical devices is expected to help the market grow in the coming years. The increase in the number of people suffering from diabetes mellitus must be assisted by a medical device capable of constantly monitoring the level of blood glucose at the crucial moment when it should increase or decrease, which is important to follow.

The pharmacological agents used in the treatment of VTE are all considered “high risk” drugs. The National Patient Safety Agency is undertaking a stakeholder consultation on the safe use of blood thinners and is expected to release guidance later this year. In the consultation document, the NPSA identified several high-risk areas, including staff skills, training, guidelines, communication and patient education.

Analysis of the Covid-19 scenario:

The COVID-19 coronavirus affects 213 countries and territories worldwide. COVID-19 has created new challenges that are forcing manufacturers to innovate at speeds never seen before. Supply chain disruptions, social distancing on high-touch assembly lines, limited ability to travel, and the need for oversight add significant complexity to current processes. The coronavirus disease 2019 (COVID-19) outbreak has created a global health crisis that has had a profound impact on the manufacturing market. There is a shortage of raw material supply from Chinese manufacturers, which has led to a serious gap between supply and demand. Manufacturers are further expected to be stuck on raw material orders due to the significant impact of the logistics industry due to the lockdown amid COVID-19. There has also been a shortage of beds in the hospital as the majority of beds are allocated to COVID-19 patients who require intensive care. All of this has affected the market, leading to a downturn in the Venous Thromboembolism Treatment market due to shortage in manpower, supply, and manufacturing.

𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬:

• This study presents the analytical description of the worldwide Venous Thromboembolism Treatment industry together with the current trends and future estimations to determine the impending pockets of investment.
• The report presents information related to key drivers, restraints and opportunities along with a detailed analysis of the global Venous Thromboembolism Treatment market share.
• Current market is quantitatively analyzed from 2020 to 2027 to highlight the growth scenario of the global Venous Thromboembolism Treatment market.
• Porter’s Five Forces analysis illustrates the power of buyers and suppliers in the marketplace.
• The report provides a detailed analysis of the Global Venous Thromboembolism Treatment Market based on the competitive intensity and how the competition will shape in the coming years.

The main players analyzed are Argon Medical Devices, Arjo, Boston Scientific, Cardinal Health (Medtronic), Cook Medical, DJO Global, Koninklijke Philips NV and Stryker.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬

Centrifuge market
Biopharmaceutical Excipients Market
sleep apnea diagnostics market

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unparalleled quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.
AMR introduces its premium subscription-based online library Avenue, designed specifically to provide a unique and cost-effective solution for businesses, investors and universities. With Avenue, subscribers can benefit from a comprehensive repository of reports on over 2,000 niche industries and over 12,000 company profiles. Additionally, users can get online access to quantitative and qualitative data in PDF and Excel formats, as well as analyst support, customization, and updated versions of reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

David Correa
Allied Analytics LLP
write to us here
Visit us on social media:

About Antoine L. Cassell

Check Also

India records success with BP treatment and control

India’s hypertension control initiative, launched in 2018, has expanded to over 100 districts India’s hypertension …

Leave a Reply

Your email address will not be published.